Lumexa Imaging Holdings

LMRI

Market cap $961M

Shares of Lantheus Holdings were added after the company received FDA approval of its key product TruVu. We used recent weakness as an opportunity to initiate a position in Talen Energy, an independent power producer whose portfolio includes the Susquehanna nuclear plant and other dispatchable generation assets. We exited Cactus as we lost confidence that its major growth lever, expansion into the Middle East, would play out in 2026 amid the escalating conflict in the region.

RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026.

Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform

Lumexa Imaging Holdings, Inc. (LMRI) Q4 2025 Earnings Call Transcript

Lumexa Imaging remains a Buy, with Q4 2025 results clarifying the medium-term growth and margin trajectory. Advanced imaging volumes and mix are rising, driving superior unit economics and margin expansion; FastScan rollout is a key throughput catalyst. De novo center openings reached a record, with rapid breakeven timelines supporting compounding organic growth and future margin upside.

SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI). The investigation focuses on Lumexa Imaging's executive officers and whether investor losses may be recovered under federal securities laws.

RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance.

RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.

Chair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, is proud to recognize Jennifer L.

Lumexa Imaging (LMRI) earns a Buy rating due to resilient outpatient imaging demand, demographic tailwinds, and a scalable business model. LMRI benefits from a secular shift toward outpatient imaging, driven by lower costs, insurer incentives, and consumer preference for convenience. The joint venture model with hospitals locks in referral flows, enhances reimbursement rates, and creates high switching costs, reinforcing LMRI's moat.